Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70601 - 70625 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	FKBP4	2288	upregulated	Silicon Dioxide results in increased expression of FKBP4 mRNA	12p13.33	A24196
Silicon dioxide	Approved	FKBP5	2289	downregulated	Silicon Dioxide analog results in decreased expression of FKBP5 mRNA	6p21.31	A24195
Silicon dioxide	Approved	FLCN	201163	upregulated	Silicon Dioxide analog results in increased expression of FLCN mRNA	17p11.2	A24195
Silicon dioxide	Approved	FLRT2	23768	downregulated	Silicon Dioxide analog results in decreased expression of FLRT2 mRNA	14q31.3	A24195
Silicon dioxide	Approved	FLRT3	23767	upregulated	Silicon Dioxide analog results in increased expression of FLRT3 mRNA	20p12.1	A24194
Silicon dioxide	Approved	FLT1	2321	upregulated	Silicon Dioxide analog results in increased expression of FLT1 mRNA	13q12.3	A24194
Silicon dioxide	Approved	FLT3LG	2323	upregulated	Silicon Dioxide analog results in increased expression of FLT3LG mRNA	19q13.33	A24195
Silicon dioxide	Approved	FMN2	56776	downregulated	Silicon Dioxide analog results in decreased expression of FMN2 mRNA	1q43	A24194
Silicon dioxide	Approved	FMN2	56776	upregulated	Silicon Dioxide analog results in increased expression of FMN2 mRNA	1q43	A24195
Silicon dioxide	Approved	FMNL2	114793	upregulated	Silicon Dioxide analog results in increased expression of FMNL2 mRNA	2q23.3	A24195
Silicon dioxide	Approved	FMO2	2327	downregulated	Silicon Dioxide analog results in decreased expression of FMO2 mRNA	1q24.3	A24194
Silicon dioxide	Approved	FMO4	2329	downregulated	Silicon Dioxide analog results in decreased expression of FMO4 mRNA	1q24.3	A24195
Silicon dioxide	Approved	FMO5	2330	downregulated	Silicon Dioxide analog results in decreased expression of FMO5 mRNA	1q21.1	A24195
Silicon dioxide	Approved	FMOD	2331	downregulated	Silicon Dioxide analog results in decreased expression of FMOD mRNA	1q32.1	A24195
Silicon dioxide	Approved	FN1	2335	downregulated	Silicon Dioxide analog results in decreased expression of FN1 mRNA	2q35	A24195
Silicon dioxide	Approved	FNDC3A	22862	upregulated	Silicon Dioxide analog results in increased expression of FNDC3A mRNA	13q14.2	A24195
Silicon dioxide	Approved	FNDC4	64838	downregulated	Silicon Dioxide analog results in decreased expression of FNDC4 mRNA	2p23.3	A24195
Silicon dioxide	Approved	FNDC4	64838	upregulated	Silicon Dioxide results in increased expression of FNDC4 mRNA	2p23.3	A24196
Silicon dioxide	Approved	FNDC5	252995	upregulated	Silicon Dioxide analog results in increased expression of FNDC5 mRNA	1p35.1	A24194
Silicon dioxide	Approved	FNDC8	54752	upregulated	Silicon Dioxide analog results in increased expression of FNDC8 mRNA	17q12	A24195
Silicon dioxide	Approved	FNIP1	96459	upregulated	Silicon Dioxide analog results in increased expression of FNIP1 mRNA	5q31.1	A24194
Silicon dioxide	Approved	FOLH1	2346	downregulated	Silicon Dioxide analog results in decreased expression of FOLH1 mRNA	11p11.12	A24195
Silicon dioxide	Approved	FOLR1	2348	downregulated	Silicon Dioxide analog results in decreased expression of FOLR1 mRNA	11q13.4	A24195
Silicon dioxide	Approved	FOLR3	2352	upregulated	Silicon Dioxide analog results in increased expression of FOLR3 mRNA	11q13.4	A24194
Silicon dioxide	Approved	FOS	2353	downregulated	Silicon Dioxide analog results in decreased expression of FOS mRNA	14q24.3	A24195

Displaying entries 70601 - 70625 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability